STOCK TITAN

DarioHealth to Participate in 10th Annual SVB Leerink Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

DarioHealth Corp. (Nasdaq: DRIO) is set to participate in the 10th Annual SVB Leerink Global Healthcare Conference from February 24 to 26, 2021. CEO Erez Raphael will host investor meetings during the event, emphasizing Dario's role in the digital therapeutics market. The company is known for its AI-powered solutions aimed at chronic condition management, particularly in diabetes and hypertension. DarioHealth is expanding its reach across various health conditions and geographic markets, focusing on personalized experiences and evidence-based interventions.

Positive
  • None.
Negative
  • None.

NEW YORK, Feb. 19, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that Erez Raphael, Chief Executive Officer, is scheduled to participate and host investor meetings at the 10th Annual SVB Leerink Global Healthcare Conference that is scheduled to take place from February 24 to 26, 2021.

About DarioHealth Corp.

DarioHealth Corp. (Nasdaq: DRIO) is a leading global digital therapeutics company revolutionizing how people with chronic conditions manage their health. Dario's next-generation, AI-powered, digital therapeutic solutions support more than just an individual's disease. Dario provides adaptive, personalized experiences that drive behavior change through evidence-based interventions, intuitive, clinically proven digital tools, high-quality software, and coaching to help individuals improve health and sustain meaningful outcomes. Dario offers one of the highest-rated diabetes and hypertension solutions on the market. The company's cross-functional team operates at the intersection of life sciences, behavioral science, and software technology and is rapidly expanding into new chronic conditions and geographic markets, using a performance-based approach to improve its users' health. Dario makes the right thing to do the easy thing to do. To learn more about DarioHealth and its digital health solutions, or for more information, visit http://dariohealth.com.

DarioHealth Corporate Contact:
Suzanne Bedell
VP Marketing
suzanne@dariohealth.com
+1-347-767-4220

Investor Relations Contact:
Chuck Padala
chuck@lifesciadvisors.com
+1-646-627-8390

Media Contact:
Natalie Joslin
dariohealth@mergeworld.com
+1 301-233-7907

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/dariohealth-to-participate-in-10th-annual-svb-leerink-global-healthcare-conference-301231638.html

SOURCE DarioHealth Corp.

FAQ

When will DarioHealth participate in the SVB Leerink Global Healthcare Conference?

DarioHealth will participate in the conference from February 24 to 26, 2021.

Who is representing DarioHealth at the conference?

CEO Erez Raphael will represent DarioHealth at the conference and host investor meetings.

What is the stock symbol for DarioHealth?

The stock symbol for DarioHealth is DRIO.

What solutions does DarioHealth offer for chronic conditions?

DarioHealth offers AI-powered digital therapeutic solutions primarily for diabetes and hypertension.

What type of company is DarioHealth?

DarioHealth is a global leader in digital therapeutics focused on chronic condition management.

DarioHealth Corp.

NASDAQ:DRIO

DRIO Rankings

DRIO Latest News

DRIO Stock Data

27.93M
30.03M
14.28%
27.47%
5.9%
Health Information Services
Surgical & Medical Instruments & Apparatus
Link
United States of America
NEW YORK